Drew Ranieri : Hi, Leslie and Nabeel. Thanks for the taking the question. Maybe actually just to piggyback off of the last question, Leslie you mentioned your now see multiple program sending low double digits of patient’s home, and I mean that’s really encouraging. I understand that it’s De Novo mainly now, but I guess how are you kind of thinking about the PD opportunity and the eventual burnout that kind of results from using that as a ï¬rst home therapy? And maybe just how are you kind of thinking about like the low double digits growing to even further in ’23? Just trying to get a better sense of that and any potential catalysts that you can point us to for ’23 for new products or the VA relationships? Just anything on those two topics. Thank you.
Leslie Trigg: Sure. Happy to. I’m just getting those VA new products. Well yeah, let me start with the home and PD. And you said we do have some examples of low double digits and could it grow further? Short answer, absolutely yes. We have not found the ceiling yet, which I ï¬nd really exciting. I think in the past, maybe there’s been a historical assumption that you know oh, you can only ever really send X number of patients homes in a given location, and that’s just not been our experience. I think it again speaks to the simplicity of the device. I think it speaks to the experience that our team creates for each patient and our goal has always been to really open up the envelope and cash who can be successful at home.
And we’ve seen that over and over again in our demographic and so far we’ve just not found any limits in terms of age or education or income status. We see equivalent ease with Tablo really across the population. So I don’t yet see a ceiling and how could we grow up further and how high could it get, more time on task. I think more to be revealed as time marches forward, but I am very, very bullish on how big these home programs could get over time and obviously as they do, that makes us incredibly efficient with our own team’s time. I’m also really very, very excited about PD in the future as a funnel flow into HHC. What I ï¬nd unbelievable and almost criminal is that the vast majority of patients who are already successful on home with PD end up in clinic.
It’s like 98% transition of PD in the home into in-center dialysis. It makes absolutely no sense. They’ve already shown themselves to be thriving at home, what an opportunity to keep successful people at home, and HHD a transition from PD to HHD would be a terriï¬c way to do that. How do we do that? Well, in partnership with providers, educating that population much, much earlier. That will be €“ that will take time. You know it’s a work in progress. It’ll take a lot more educational time, which we intend to do with physicians, with home training nurses, with test. I think we’ve got to get the mindset evolved to one in which HHD is the ï¬rst option and what is offered ï¬rst to PD patients who have to transition off PD, which typically happens at around the two-year plus mark.
